• METTL3-mediated m6A modification stabilizes Nectin-4 mRNA, enhancing its expression in ESCC.
• Nectin-4 promotes ESCC malignant phenotypes including proliferation, migration, and invasion.
• VNN1 is identified as a downstream effector of Nectin-4, linking the METTL3/Nectin-4 axis to metabolic reprogramming.
• The METTL3/Nectin-4/VNN1 axis offers novel biomarkers and therapeutic targets for ESCC.
Download Full PDF: METTL3-mediated m6A modification facilitates Nectin-4-induced VNN1 upregulation and promotion of ESCC progression | SinoBioData | SinoBioData